Livzon Pharmaceutical Group Inc. - Current Ratio

The Current Ratio as of August 2026 (TTM) for Livzon Pharmaceutical Group Inc. (1513.HK) is 1.96

According to Livzon Pharmaceutical Group Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.96. This represents a change of -9.20% compared to the average of 2.16 of the last 4 quarters.

Livzon Pharmaceutical Group Inc. (1513.HK) Historical Current Ratio (quarterly & annually)

How has 1513.HK Current Ratio performed in the past?

The mean historical Current Ratio of Livzon Pharmaceutical Group Inc. over the last ten years is 2.25. The current 1.96 Current Ratio has changed 8.62% with respect to the historical average. Over the past ten years (40 quarters), 1513.HK's Current Ratio was at its highest in in the September 2018 quarter at 2.84. The Current Ratio was at its lowest in in the June 2016 quarter at 1.24.

Livzon Pharmaceutical Group Inc. (1513.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Livzon Pharmaceutical Group Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Livzon Pharmaceutical Group Inc. (1513.HK) Average Current Ratio

How has 1513.HK Current Ratio performed in the past?

The current Current Ratio of Livzon Pharmaceutical Group Inc. (1513.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Livzon Pharmaceutical Group Inc. (1513.HK) Current Ratio vs. Peers

How is 1513.HK’s Current Ratio compared to its peers?

Livzon Pharmaceutical Group Inc.’s Current Ratio is less than China Medical System Holdings Limited (6.33), greater than China Resources Pharmaceutical Group Ltd. (1.42), greater than Grand Pharmaceutical Group Limited (1.14), less than Xuanzhubio-b (3.75), greater than The United Laboratories International Holdings Limited (1.83), greater than Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (1.60), less than Simcere Pharmaceutical Group Limited (2.21), less than Asymchem Laboratories (Tianjin) Co., Ltd. (5.69), less than HUTCHMED (China) Limited (4.96), greater than Shanghai Henlius Biotech, Inc. (0.71),

Build a custom stock screener for Livzon Pharmaceutical Group Inc. (1513.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Livzon Pharmaceutical Group Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Livzon Pharmaceutical Group Inc. (1513.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Livzon Pharmaceutical Group Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.